Telik, Inc. Earnings Conference Call (Q1 2008)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other May 8 Calls Today's Calls

Call Details Telik, Inc. Earnings Conference Call (Q1 2008) Thu, May 8, 2008, 4:30 pm Eastern Listen to the archived event audio About Telik, Inc. (NasdaqGM:TELK) Telik, Inc., a biopharmaceutical company, engages in the discovery and development of small molecule therapeutics for the treatment of cancer and inflammatory diseases. Its products include TELCYTA, a small molecule cancer drug product candidate designed to be activated in cancer cells, which is in Phase III clinical trials; TELINTRA, a Phase II clinical trial product, which is a small molecule bone marrow stimulant for the treatment of blood disorders associated with low blood cell levels; and TLK58747, a preclinical testing product, which causes apoptosis and G2/M cell cycle arrest in human cancer cell lines. The company has collaborative agreements for screening services with Sanwa Kagaku Kenkyusho Co., Ltd.; and screening and license agreement with Hoffmann-La Roche, Inc. Telik, Inc. was founded in 1988 as Terrapin Diagnostics, Inc. and changed its name to Telik, Inc. in 1998. The company is based in Palo Alto, California. More Info: Quote | Chart | News | Profile | Reports | Research | SEC | Msgs | Insider | Financials | Analyst Ratings